Literature DB >> 1277295

Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis.

D B Budzko, P J Lachmann, I McConnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1277295     DOI： 10.1016/0008-8749(76)90011-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  21 in total

1.  The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.

Authors:  R G Leslie
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

2.  In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.

Authors:  A B Wilson; P J Lachmann; R R Coombs
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

3.  Complement components and lymphoid cell surfaces.

Authors:  I McConnell
Journal:  Proc R Soc Med       Date:  1976-09

4.  Antibody-independent activation of the alternative complement pathway in human serum by parasitic cells.

Authors:  F Kierszenbaum; D Weinman
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

5.  Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL).

Authors:  H V Marquart; K Grønbaek; B E Christensen; S E Svehag; R G Leslie
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.

Authors:  J G Sissons; M B Oldstone; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

7.  Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.

Authors:  O F Ramos; G Sármay; E Klein; E Yefenof; J Gergely
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.

Authors:  E H Olesen; A A Johnson; G Damgaard; R G Leslie
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

9.  Antibody-independent complement activation by a subpopulation of mitogen-induced human T lymphoblasts.

Authors:  M J Martin; J Vega; C Gutiérrez
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

10.  Cell-surface bound complement regulatory activity is necessary for the in vivo survival of KDH-8 rat hepatoma.

Authors:  L Baranyi; K Baranji; H Takizawa; N Okada; H Okada
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.